From: Nomogram-based risk prediction of macrosomia: a case-control study
Index | Non-macrosomia group (n = 1454) | Macrosomia group (n = 95) | P value |
---|---|---|---|
Age (years) | 30.91 ± 3.64 | 31.46 ± 3.65 | 0.148 |
< 25 | 30 (2.1%) | 1 (1.1%) | |
25–34 | 1175 (80.8%) | 73 (76.8%) | |
≥ 35 | 249 (17.1%) | 21 (22.1%) | 0.387 |
Prepregnancy BMI (kg/m2) | 21.84 ± 2.97 | 23.13 ± 3.12 | < 0.001 |
< 24 | 1169 (80.4%) | 60 (63.2%) | |
24–28 | 225 (15.5%) | 22 (23.2%) | |
≥ 28 | 60 (4.1%) | 13 (13.7%) | < 0.001 |
Gestational weight gain (kg) | 12.53 ± 5.62 | 14.97 ± 5.09 | < 0.001 |
Parity | |||
0 | 906 (62.3%) | 46 (48.4%) | |
≥ 1 | 548 (37.7%) | 49 (51.6%) | 0.007 |
History of macrosomia | |||
Yes | 30 (2.1%) | 34 (35.8%) | |
No | 1424 (97.9%) | 61 (64.2%) | < 0.001 |
History of GDM/DM | |||
Yes | 278 (19.1%) | 29 (30.5%) | |
No | 1176 (80.9%) | 66 (69.5%) | 0.007 |
History of HDP | |||
Yes | 18 (1.2%) | 3 (3.2%) | |
No | 1436 (98.8%) | 92 (96.8%) | 0.267 |
SBP (mmHg) | 109.73 ± 9.97 | 111.64 ± 9.43 | 0.071 |
DBP (mmHg) | 65.92 ± 9.15 | 67.53 ± 9.85 | 0.100 |
ALT (U/L) | 17.01 ± 3.59 | 17.92 ± 8.51 | 0.303 |
AST (U/L) | 18.27 ± 8.96 | 19.08 ± 15.27 | 0.416 |
ALB (g/L) | 44.18 ± 2.50 | 43.72 ± 2.28 | 0.085 |
TC (mmol/L) | 3.93 ± 0.70 | 4.13 ± 0.91 | 0.046 |
TG (mmol/L) | 0.99 ± 0.60 | 1.18 ± 0.69 | 0.010 |
HDL-C (mmol/L) | 1.42 ± 0.36 | 1.41 ± 0.26 | 0.805 |
LDL-C (mmol/L) | 2.55 ± 1.07 | 2.23 ± 0.62 | 0.768 |
SCr (umol/L) | 49.97 ± 12.41 | 49.72 ± 6.41 | 0.845 |
UA (umol/L) | 213.58 ± 50.81 | 222.13 ± 54.16 | 0.114 |
HbA1c (%) | 5.12 ± 0.27 | 5.27 ± 0.71 | 0.047 |
FPG (mmol/L) | 4.91 ± 0.27 | 5.00 ± 0.59 | 0.151 |
CRP (mg/L) | 2.00 ± 2.30 | 3.05 ± 3.56 | 0.005 |
FT4 (pmol/L) | 17.45 ± 7.65 | 16.51 ± 2.51 | 0.232 |
FT3 (pmol/L) | 4.79 ± 2.29 | 4.65 ± 0.57 | 0.545 |
TSH (mU/L) | 1.89 ± 1.72 | 1.92 ± 1.33 | 0.852 |